Insider buying last 90 days
No open-market insider purchases were filed for NHI in the last 90 days.
From Form 4 filings, dated to when each was filed.
Every NHI insider filing, plotted on the chart in Gekko.Open NHI in Gekko
National Health Investors (NHI) Stock Analysis & Forecast
Oct 12 close
$65.62+0.77 (+1.2%)
Gekko Brief
AI summaryOct 12 closeNational Health Investors trades near its 52-week low this week, with shares touching $64.51 ahead of the company's third-quarter 2026 earnings release scheduled after market close on November 9, with a conference call November 10. Analyst views are mixed: Argus issued a HOLD rating and lowered its target price to $62.00 from $65.28, while BMO Capital maintained a Buy rating with an $80.00 target, citing a Strong Buy consensus for the stock. Coverage has also noted scrutiny of the company's senior-housing strategy despite a slight revenue increase reported previously.
NHI closed at $65.62, up 1.2%, but remains below both its 50-day average of $70.17 and 200-day average of $77.17, with the 50-day sitting below the 200-day. The GekkoIndex reading of 64.4 places the stock in the Accumulation zone. Price sits 42.4% below Gekko Fair Value of $113.92.
Over the next 20 trading days, the next earnings date on 9 November falls inside that window, with the prior quarter showing a $1.22 actual EPS against a $1.26 estimate and a -7.1% reaction. No insider, Congress, or unusual options activity appears in the respective 90-day and 30-day windows. Seasonality from this point in the calendar has averaged a 1.9% gain over the next 20 trading days across 5 years, rising in 4 of them. Consensus among 5 firms stands at 4 buy and 1 hold, with a $81.88 target.
Written by AI from the Oct 12, 2026 close and checked automatically against the figures on this page.
National Health Investors price vs fair value
Close $65.62200-day averageGekko Fair Value $113.92
National Health Investors quick facts
- Market cap
- $3.18B
- P/E ratio
- 18.7
- Forward P/E
- 18.2
- EPS, TTM
- $3.46
- Revenue, TTM
- $435.8M
- Profit margin
- 38.3%
- Dividend yield
- 5.75%
- Beta
- 0.52
- Volume
- 248,474 avg 403,111
- 1-year return
- −11.1%
- Typical daily move
- ±1.7%
- Typical 20-day move
- ±4.5%
- 50-day average
- $70.17
- 200-day average
- $77.17
- Next earnings
- Nov 9
- Shares outstanding
- 49.11M
National Health Investors swing-trade checklist
National Health Investors scores 3 supportive, 0 mixed and 2 headwinds across the 5 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
3 supportive0 mixed2 headwinds
- Trendheadwind
Below 50 and 200-day
Close $65.62 is below the 50-day ($70.17) and 200-day ($77.17) averages, and the 50-day is below the 200-day.
See the chart - GekkoIndexsupportive
64.4, Accumulation
Reading 64.4 is in the Accumulation zone.
See the GekkoIndex - Fair valuesupportive
42.4% below
Price is 42.4% below Gekko Fair Value (more than 5% below).
See fair value - Smart moneyno data
No data
No insider, Congress or unusual options activity in the window.
See smart money - Earnings riskheadwind
Reports in 28 days
Reports on Nov 9, 2026, 28 days away — inside a typical 20-trading-day hold.
See earnings - Seasonalitysupportive
+1.9% on average
From this point in the calendar, the next 20 trading days averaged +1.9% over 5 years, rising in 4 of them.
See seasonality
A description of current data, not a recommendation. How this page works
National Health Investors stock chart and price history
National Health Investors closed at $65.62 on Oct 12, 2026, −11.1% over the past year, inside a 52-week range of $63.51 to $91.38.
Close50-day average200-day averageVolume
Use the left and right arrow keys to read daily values.
Performance Breakdown
- 1 month
- −6.7%
- 3 months
- −13.8%
- 6 months
- −23.1%
- 1 year
- −11.1%
The full NHI chart adds GekkoIndex, insider, options, Congress and hedge fund markers, plus TrendCandles™.Open NHI in Gekko
Follow National Health Investors through every session
Put NHI on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Track NHI in GekkoFree for 7 days. No credit card required.
National Health Investors GekkoIndex: the smart money zone
National Health Investors’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 64.4, in the Accumulation zone, down 7.4 points over five sessions.
64.4Accumulation
Down 7.4 points over five sessions, from the Buying zone.
Reading for Oct 12, 2026
What followed past readings in each zone
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 31 | −0.6% | −0.2% | ||
| Accumulation (current zone) | 213 | +0.1% | +0.5% | ||
| Neutral | 348 | +0.1% | +0.6% | ||
| Distribution | 43 | +0.7% | +0.9% | ||
| Selling | 0 | Not available | |||
Average NHI share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Accumulation readings averaged +2.2% over 20 days. Past behaviour doesn’t guarantee future results.
Accumulation zone: Institutional interest building. About the five zones →
See every daily GekkoIndex reading plotted over the NHI price, zone by zone.Track NHI in Gekko
Is National Health Investors stock overvalued? Gekko Fair Value
National Health Investors trades 42.4% below Gekko Fair Value of $113.92, so the shares are undervalued on Gekko’s estimate.
Gekko’s own estimate of what National Health Investors shares are worth, recalculated every trading day.
$113.92
Gekko Fair Value, Oct 10, 2026
42.4% Undervalued
At the end of Aug 2026 the price was 10.9% below the estimate.
Gekko Fair ValueShare price, month end
Gekko Fair Value on every chart, with the gap to price updating daily.Open NHI in Gekko
National Health Investors insider and Congress trading
No open-market insider purchases were filed for National Health Investors, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
Congress trades last 90 days
No trades in NHI were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Congress disclosures for NHI, plotted on the chart in Gekko.Open NHI in Gekko
Buybacks
National Health Investors has been buying back its own shares.
- Bought back, quarter ended Sep 30, 2024
- $5.42M
- As a share of market cap
- 0.17%
From company filings.
National Health Investors earnings: next date and track record
National Health Investors reports on Nov 9, 2026 (28 days away), and beat the EPS estimate in 4 of its last 8 reports.
Next earnings report
Nov 9, 2026
28 days away
- EPS estimate
- $1.18
- Revenue estimate
- $68.53M
4 of 8reports beat the EPS estimate
±2.7%average move across the report
5 of 8reports followed by a gain
Share-price move across each report
Last earnings call, Aug 10, 2026 AI summary
- What they said
- NHI completed $237.2 million in year-to-date investments at 7.7% average yield, with SHOP investments growing 137% to ~$850 million (24% of total). The NHC portfolio sale closed July 1, significantly reducing leverage below long-term targets and strengthening liquidity. SHOP same-store results improved from Q1, with newer acquisitions performing within original assumptions. New COO Chris Maingot and CFO Todd Siefert joined to support expanded SHOP platform growth.
- Guidance
- Full-year outlook remains unchanged following in-line Q2 performance. Management sees accelerating acquisition opportunities supported by strong post-NHC balance sheet liquidity. Industry tailwinds from aging demographics and historically low new construction expected to persist.
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Aug 10, 2026 | $1.22 est $1.26 | $71.39M est $72.12M | −7.1% |
| May 4, 2026 | $0.77 est $0.86 | $73.15M est $70.22M | −4.7% |
| Feb 26, 2026 | $0.76 est $0.79 | $70.29M est $69.04M | −4.6% |
| Nov 6, 2025 | $0.69 est $0.65 | $89.85M est $95.12M | +0.8% |
| Aug 6, 2025 | $0.79 est $0.75 | $91.39M est $85.66M | +1.7% |
| May 5, 2025 | $0.74 est $0.71 | $89.30M est $86.18M | +0.6% |
| Feb 25, 2025 | $0.81 est $0.75 | $85.76M est $81.13M | +0.7% |
| Nov 5, 2024 | $0.65 est $0.73 | $82.94M est $83.81M | +1.1% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
National Health Investors stock forecast and analyst price targets
Analysts’ average 12-month price target for National Health Investors is $81.88, +24.8% from the last close, from 5 firms rating the stock in the last 90 days.
$81.88consensus 12-month target, +24.8% from the last close
Now $65.62Avg $81.88
Low $78High $90
Each firm’s latest rating in the last 90 days: 5 firms.
Latest analyst actions
| Date | Firm | Target | vs price |
|---|---|---|---|
| Oct 5 | BMO Capital | $80 | +21.9% |
| Sep 23 | BMO Capital | $80 | +21.9% |
| Sep 2 | Truist Financial | $80 | +21.9% |
| Sep 1 | Wells Fargo | $78 | +18.9% |
| Aug 24 | Bank of America Securities | $86 | +31.1% |
+0.5%average 20-day move after past Accumulation readings
+1.9%average move over the next 20 trading days in the last 5 years
±1.7%typical daily move, from the 14-day average range
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
National Health Investors seasonality: the next 20 trading days
Over the next 20 trading days from Oct 10, National Health Investors averaged +1.9% across the last 5 years, rising in 4 of them.
Next 20 trading days, by year
Average move and hit rate
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | +2.4% | 4 of 5 |
| Next 10 trading days | +2.0% | 4 of 5 |
| Next 15 trading days | +2.2% | 3 of 5 |
| Next 20 trading days | +1.9% | 4 of 5 |
| Next 30 trading days | +4.4% | 4 of 5 |
For scale, NHI’s typical 20-trading-day move in either direction is about 4.5%.
National Health Investors market cap and key statistics
National Health Investors’s market cap is $3.18B, with a P/E ratio of 18.7 and revenue of $435.8M over the last twelve months.
Valuation
- Market cap
- $3.18B
- P/E ratio
- 18.7
- Forward P/E
- 18.2
- EPS, TTM
- $3.46
- Gekko Fair Value
- $113.92
Trading
- Volume
- 248,474
- Avg volume, 20 days
- 403,111
- 52-week high
- $91.38
- 52-week low
- $63.51
- Shares outstanding
- 49.11M
Financials
- Revenue, TTM
- $435.8M
- Profit margin
- 38.3%
- Return on equity
- 10.7%
- Quarterly earnings growth, YoY
- +45.2%
Risk and income
- Beta
- 0.52
- Typical daily move
- ±1.7%
- Typical 20-day move
- ±4.5%
- Dividend yield
- 5.75%
National Health Investors stock news this week
Coverage of National Health Investors this week reads neutral: 1 positive, 5 neutral and 1 negative headlines.
- National Health Investors, Inc. (NHI) Stock ForecastsYahoo! Finance Canada, Oct 12
- 111,027 National Health Investors, Inc. $NHI Shares Sold by Sound Income Strategies LLCMarketBeat, Oct 9
- National Health Investors to release Q3 2026 earnings on Nov 9, with a conference call on Nov 10.Pluang, Oct 8
- NHI stock heads toward November 9 results near a 52-week lowAD HOC NEWS, Oct 8
- NHI stock hits 52-week low at 64.51 USDInvesting.com, Oct 7
- NHI Announces Third Quarter 2026 Earnings Release and Conference Call DatesMorningstar, Oct 7
National Health Investors stock FAQ
What is National Health Investors’s market cap?
National Health Investors’s market cap is $3.18B at the Oct 12, 2026 close of $65.62, with 49.11M shares outstanding. The shares trade on a P/E ratio of 18.7.
What is the National Health Investors stock forecast?
The consensus analyst 12-month price target for National Health Investors is $81.88, +24.8% from the last close. Of the 5 firms that rated the stock in the last 90 days, 4 rate it a buy, 1 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.
Is National Health Investors stock overvalued or undervalued?
On Gekko’s estimate National Health Investors is undervalued: the Oct 12, 2026 close of $65.62 is 42.4% below Gekko Fair Value of $113.92. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
When does National Health Investors report earnings next?
National Health Investors is expected to report on Nov 9, 2026 (28 days away). Analysts expect earnings of $1.18 per share on revenue of $68.53M. National Health Investors beat the earnings estimate in 4 of its last 8 reports, moving 2.7% on average across the report.
What is National Health Investors’s 52-week high and low?
National Health Investors’s 52-week high is $91.38 and its 52-week low is $63.51; it closed at $65.62 on Oct 12, 2026, −11.1% over the past year.
Is National Health Investors stock a buy right now?
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 3 of the 5 items with data read as supportive (gekkoindex, fair value and seasonality) and 2 as headwinds (trend and earnings risk). The checklist is a description of current data, not a recommendation.
How this page works
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
See National Health Investors the way Gekko members do
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,408 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.